K. Shima

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Utsumi, S. Kiuchi, Yoshinobu Nakamaru, 2012, Bioorganic & medicinal chemistry.

N-Carbamylamino Alcohols as the Precursors of Oxazolidinones via Nitrosation-Deamination Reaction

H. Ohta, T. Sugai, S. Nishiyama, 2000 .

Synthetic Study on a 26-Membered Macrolide, Amphidinolide B: Synthesis of the C1—C13 Fragment

S. Nishiyama, S. Ohba, Katsuhide Ohi, 1998 .

Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis

T. Ohtsuka, Masafumi Nakamura, H. Eguchi, 2017, Pancreas.

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Utsumi, S. Kiuchi, Yoshinobu Nakamaru, 2012, Bioorganic & medicinal chemistry.

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis

T. Ohtsuka, Masafumi Nakamura, H. Eguchi, 2023, International Journal of Clinical Oncology.